This article from FiercePharma talks about the release of 2019 Health Trend Ten eBook by Syneos Health, which outlines critical shifts impacting drug development and commercialization.
Read ArticleeBook Provides Biopharma Decision Makers With What’s-Next Insights to Navigate Challenges and Capitalize on the Opportunities Ahead
Read ArticleThe first of the two episodes on the 2019 Health Trend Ten discusses key commercial trends that will impact the healthcare industry going into 2019.
ListenMedia June 6, 2019
In this PharmaTimes article, Dan Spacie, President, Syneos Health Selling Solutions, Europe, comments about the changes in the pharma sales ecosystem.
Media June 6, 2019
Future commercial models will see radical reorganisation in the coming years.
Media June 3, 2019
Our experts crafted a checklist for Pharmaceutical Executive that can be used to determine if there’s hidden vitality left in aging oncology brands and inspire outside-of-the-box, often low-investment solutions to grow the bottom line.
Media June 3, 2019
Erwin De Cock, principal for real world and late phase development at Syneos Health, speaks to pharmaphorum at the eyeforpharma conference in Barcelona about our Biopharmaceutical Acceleration Model and the increasing importance of real-world evidence.
Media May 30, 2019
Patients are moving away from social media and seeking information on channels not typically associated with patient recruitment – forums. Learn more on this trend from Marie Emms and Rowena Kam in the Journal for Clinical Studies (page 50).
Media May 16, 2019
Carolyn Stephenson, our SVP, Director of Insights, shares her thoughts with PM360 regarding why we should lean on cognitive psychology to pinpoint and remove friction, freeing HCPs time to spend with patients.
Media May 16, 2019
Drug pricing regulation is on the horizon and it could affect everything from marketing to pipelines. Meg Alexander, our Head of Reputation & Risk Management, explains what's on the table and the potential implications.
Media May 16, 2019
Now is a great time for pharma marketers to embrace behavioral science. Discover why in a recent MM&M eBook featuring our resident behavioral scientist, Kathleen Starr, Ph.D.
Media May 1, 2019
What pressures are prompting changes in commercialization and in what ways do pharmaceutical companies need to change in order to keep up?
Media April 15, 2019
John Seay of our Managed Markets Communications team spoke with PM360 about proposed HHS changes and the impact they will have on rebates and pricing.
Media April 11, 2019
How can we use evidence-based strategies to make change a reality for our customers & the patients they serve? Michelle Keefe, President of Commercial Solutions at Syneos Health, elaborates in this Applied Clinical Trials article.
Media April 10, 2019
Adrian Garcia, SVP, Managed Markets at GSW, a Syneos Health company, shares his thoughts with Medical Marketing & Media (MM&M) on what strategies position brands for success
Media March 18, 2019
Nicky Walsby, MD PR UK, Syneos Health Communications, is featured in the latest edition of PRWeek UK Power Book 2019.
Media March 14, 2019
A commercial model built to deliver blockbuster drugs to the market is no longer effective – particularly for delivering therapies for complex disease states to smaller, more targeted patient populations and specialty providers.
Media March 12, 2019
Amanda Joly, EVP, Brand and Experience Strategy at GSW, a Syneos Health company, talks about the "Speak People approach" in this PM360 article.
Media March 4, 2019
In this PharmaVOICE article, Drew Beck, VP, Director of Innovation, Syneos Health Communications, talks about how healthcare brands can co-create with customers to uncover better real world solutions in advisory boards.
Media March 1, 2019
Some of healthcare's biggest challenges are based in counterintuitive patient behavior. Outsourcing-pharma.com article featuring Kathleen Starr, Managing Director, Behavioral Insights at Syneos Health, outlines how behavioral science can help address the issues.
Media February 26, 2019
PMLiVE's Gemma Jones interviews Nicky Walsby, Managing Director PR UK at Syneos Health Communications.
Media February 21, 2019
You’re not missing out in your use of social media in pharma comms, says Duncan Arbour, our SVP Innovation, Europe.
Media February 6, 2019
Why is healthcare one of the top industries seeing the greatest profit in artificial intelligence? Beyond its obvious benefit to drug discovery, what are the aspects of AI that are particularly useful to sales and marketing?
Media January 31, 2019
Leigh Householder, EVP/ Managing Director of Insights and Innovation at Syneos Health writes about the shift towards more personalised labels with the most impact on the right patient - taken from SyneosHealth 2019 Health Trend Ten.
Media January 31, 2019
Nicky Walsby, MD UK PR at Syneos Health Communications talks about the opportunities digital brings for more patient-centric communications.
Media January 31, 2019
Thunicia Moodley, Senior Engagement Manager, Syneos Health Consulting discusses key 2019 trends for pharma launches in this PMLiVE article.
Media January 18, 2019
This PMLiVE article focuses on four broad areas that pharma should consider to prepare best for launch.
Media January 18, 2019
In this PM360 article, Julian Suchman, Digital Strategist at Syneos Health, talks about why Facebook remains an effective channel for pharma marketers in 2019.
Media January 11, 2019
Duncan Arbour, SVP Innovation and Alex Brock, Head of Digital, both at Syneos Health Communications Europe, together with Skye Hodson, Engagement Manager, Syneos Health Consulting share some insights on where digital health technology is heading.
Media January 11, 2019
Syneos Health examines some of the key trends shaping industry launches in 2019 and beyond.
Media January 8, 2019
Access to an increasing amount of information is catalyzing research, while also lending to higher levels of professional burnout on behalf of health care professionals, says company executive.
Media January 7, 2019
In this eyeforpharma article, David Thompson, SVP, Real World and Late Phase, at Syneos Health, says that pragmatic clinical trials (PCTs) will be a growth area in 2019.
Media January 7, 2019
Duncan Arbour, SVP Innovation, Syneos Health Communications Europe, spoke with PharmaPhorum about the Syneos Health Trends Ten report.
Already have a RSS feed reader?
